Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier)

This study is ongoing, but not recruiting participants.

Study NCT00575055 Information provided by JANSSEN Alzheimer Immunotherapy Research & Development, LLC

First Received: December 10, 2007 Last Updated: October 11, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	April 2012 (Final data collection date for primary outcome measure)